Article
The effects of genetic polymorphism on toxicity and pharmacokinetics of methotrexate in Egyptian adult patients with leukaemia or lymphoma.
Xenobiotica; the fate of foreign compounds in biological systems - 1 Feb 2024
Shendy Khloud, Abdelkawy Khaled, Ali Ahmed Amin, Belal Fathalla, Abdelhakiem Mostafa, Magdy Galal, Anber Nahla, Elbarbry Fawzy
Abstract excerpt
Polymorphisms in genes coding folate-metabolising enzymes might alter the pharmacokinetics and sensitivity for methotrexate "MTX".The aim of the study aimed to investigate the influence of MTHFR C677T, DHFR19 Ins/del, GGH -401 C > T, and MTR A2756G polymorphisms on MTX toxicity and pharmacokinetics in Egyptian patients with Acute lymphoblastic leukaemia (ALL) or Non-Hodgkin lymphoma (NHL).Fifty adult Egyptian...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
